Clinical Trial Update: Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine [Phase 3]

View source ↗

Summary

Long-term follow-up from Phase 3 trials to demonstrate the equivalence of two vaccination schedules for the combined Hepatitis A & B vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Twinrix (Hepatitis A and B vaccine, combined)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Hepatitis A | Phase 3 | Status: COMPLETED